SMS Pharma gets FDA approval for manufacturing unit

The US regulator has approved the firm's manufacturing facility located in Andhra Pradesh


The FDA inspected the facility in April 2015

SMS Pharmaceuticals has received approval from the US Food and Drug Administration (US FDA) for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh, the company said in a regulatory filing.

The USFDA had conducted inspection of the plant in the third week of April 2015, it added.

Hyderabad-based SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email